MLKL and melanoma: Prior investigations in vivo by Van Hoecke et al. demonstrated that the intratumoral administration of mRNA encoding MLKL effectively impeded the growth and metastasis of melanoma in mouse models, displaying a synergistic interaction with anti-PD-1 immunotherapy [113].